Dose-response relationship and within-subject variability of insulin detemir and NPH insulin in subjects with type 1 diabetes

被引：0
|
作者：
Wutte, A
Plank, J
Sinner, F
Druml, T
Sommer, R
Zdravkovic, M
Ronn, BB
Draeger, E
Pieber, TR
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A152 / A152
页数：1
相关论文
共 50 条
  • [21] Maternal glycaemic control and hypoglycaemia in pregnancy: a randomised trial comparing insulin detemir with NPH insulin in 310 subjects with type 1 diabetes
    Mathiesen, E. R.
    Damm, P.
    Hod, M.
    McCance, D. R.
    Ivanisevic, M.
    Garcia, S.
    Jovanovic, L.
    DIABETOLOGIA, 2011, 54 : S486 - S487
  • [22] Insulin detemir is associated with more predictable glycemic control and lower risk of hypoglycemia compared to NPH insulin in subjects with type 1 diabetes
    Vague, P
    Selam, JL
    Skeie, S
    De Leeuw, I
    Willem, J
    Elte, F
    Haahr, H
    Kristensen, A
    Draeger, E
    DIABETES, 2002, 51 : A116 - A117
  • [23] Linear dose-response relationship of inhaled human insulin using AERx® insulin diabetes management system (AERx® iDMS) and subcutaneous human insulin in subjects with type 1 diabetes
    Plank, J
    Balent, B
    Bock, G
    Wutte, A
    Midtgaard, A
    Ronn, BB
    Pieber, TR
    DIABETES, 2004, 53 : A113 - A113
  • [24] Linear dose-response relationship and early onset of action with inhaled human insulin using AERx® insulin Diabetes Management System in subjects with Type 1 diabetes
    Plank, J
    Wutte, A
    Bock, G
    Balent, B
    Midtgaard, A
    Ronn, BB
    Pieber, T
    DIABETOLOGIA, 2004, 47 : A313 - A313
  • [25] Relationship of Insulin Dose, A1c Lowering, and Weight in Type 2 Diabetes: Comparing Insulin Glargine and Insulin Detemir
    Dailey, George
    Admane, Karim
    Mercier, Florence
    Owens, David
    DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (12) : 1019 - 1027
  • [26] Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy
    Pieber, T. R.
    Treichel, H- C.
    Hompesch, B.
    Philotheou, A.
    Mordhorst, L.
    Gall, M- A.
    Robertson, L. I.
    DIABETIC MEDICINE, 2007, 24 (06) : 635 - 642
  • [27] Dose-response relationship of oral insulin spray in healthy subjects
    Cernea, S
    Modi, P
    Kidron, M
    Raz, I
    Wohlgelernter, J
    DIABETES CARE, 2005, 28 (06) : 1353 - 1357
  • [28] Insulin detemir provides superior glycaemic control than insulin NPH or insulin glargine in type 1 diabetic subjects in a clinical setting
    Jendle, Johan H.
    Norberg, Bengt
    DIABETES, 2007, 56 : A548 - A548
  • [29] Comparison of Insulin Detemir and Insulin Glargine on Glycemic Variability in Patients with Type 1 and Type 2 Diabetes
    Tone, A.
    Iseda, I.
    Higuchi, C.
    Tsukamoto, K.
    Katayama, A.
    Matsushita, Y.
    Hida, K.
    Wada, J.
    Shikata, K.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (05) : 320 - 324
  • [30] Within-subject variability of inhaled insulin (Exubera®) versus subcutaneous regular insulin in elderly obese patients with type 2 diabetes Mellitus
    Henry, R
    Mudaliar, S
    Fryburg, D
    Becker, R
    Willavize, S
    Fisher, J
    Fountaine, R
    Sha, S
    DIABETES, 2003, 52 : A105 - A105
12345